Literature DB >> 10449184

Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships.

H K Kim1, B S Cheon, Y H Kim, S Y Kim, H P Kim.   

Abstract

Flavonoids affect the inflammatory process of the mammalian system and possess anti-inflammatory as well as immunomodulatory activities in vitro and in vivo. Since nitric oxide (NO) produced by inducible nitric oxide synthase (iNOS) is one of the inflammatory mediators, the effects of various naturally occurring flavonoids on NO production in LPS-activated RAW 264.7 cells were evaluated in vitro. Flavonoids such as apigenin, wogonin, luteolin, tectorigenin, and quercetin inhibited NO production, as measured by nitrite formation at 10-100 microM. The most active among 26 flavonoid derivatives tested were apigenin, wogonin, and luteolin, having IC50 values of 23, 17, and 27 microM, respectively, while AMT, a synthetic selective iNOS inhibitor, had an IC50 value of 0.09 microM. In contrast, flavanones, such as naringenin, and flavonoid glycosides, such as apiin, did not demonstrate significant inhibition up to 100 microM. These results clearly indicated that a C-2,3 double bond might be important, and that the potency of inhibition depended upon the substitution patterns of the flavonoid molecules. The inhibitory activity of flavonoids was not due to direct inhibition of iNOS enzyme activity because they did not reasonably inhibit iNOS activity, as measured by [3H]citrulline formation from [3H]arginine, up to 100 microM. In contrast, wogonin and luteolin concentration-dependently reduced iNOS enzyme expression, when measured by western blotting, at 10-100 microM. All these results clearly demonstrated that certain flavonoids inhibit NO production in lipopolysaccharide-activated RAW 264.7 cells, and their inhibitory activity might be due to reduction of iNOS enzyme expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449184     DOI: 10.1016/s0006-2952(99)00160-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  66 in total

1.  Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I.

Authors:  Arnab Roy Chowdhury; Shalini Sharma; Suparna Mandal; Anindya Goswami; Sibabrata Mukhopadhyay; Hemanta K Majumder
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  Luteolin prevents LPS-induced TNF-α expression in cardiac myocytes through inhibiting NF-κB signaling pathway.

Authors:  Lihua Lv; Linhua Lv; Yubi Zhang; Qiuhuan Kong
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

3.  Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.

Authors:  A Ukil; S Maity; P K Das
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

4.  Evaluation of Luteolin in the Prevention of N-nitrosodiethylamine-induced Hepatocellular Carcinoma Using Animal Model System.

Authors:  K Balamurugan; J Karthikeyan
Journal:  Indian J Clin Biochem       Date:  2011-09-30

Review 5.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 6.  Apoptotic effects of chrysin in human cancer cell lines.

Authors:  Boon Yin Khoo; Siang Ling Chua; Prabha Balaram
Journal:  Int J Mol Sci       Date:  2010-05-19       Impact factor: 5.923

7.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway.

Authors:  Sang-Rim Kang; Dae-Yong Han; Kwang-Il Park; Hyeon-Soo Park; Yong-Bae Cho; Hu-Jang Lee; Won-Sup Lee; Chung Ho Ryu; Yeong Lae Ha; Do Hoon Lee; Jin A Kim; Gon-Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-21       Impact factor: 2.629

Review 8.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

9.  Transcriptional profiling in human HaCaT keratinocytes in response to kaempferol and identification of potential transcription factors for regulating differential gene expression.

Authors:  Byung Young Kang; Sujong Kim; Ki-Hwan Lee; Yong Sung Lee; Il Hong; Mi-Ock Lee; Daejin Min; Ihseop Chang; Jae Sung Hwang; Jun Seong Park; Duck Hee Kim; Byung-gee Kim
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

10.  In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root.

Authors:  Huey-Chuan Shih; Chun-Sen Hsu; Ling-Ling Yang
Journal:  J Biomed Sci       Date:  2009-03-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.